Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Cancer Research Conferences

ESMO Symposium on Signalling Pathways in Cancer 2019

Further information »

Share this page

ESMO Symposium on Signalling Pathways in Cancer 2019

Barcelona, Spain

26 - 27 April 2019

(Click here to add to your Calendar)

The 7th edition of the ESMO Symposium on Signalling Pathways in Cancer, in partnership with the European Association for Cancer Research (EACR), will focus on Gene fusions: from gene architecture evolution, cell addiction and exploring new therapeutic opportunities. 

The aim of the symposium is to foster strategic collaboration among basic scientists, translational and clinical researchers to discuss diagnostic challenges and the future of new therapies. Focusing on the topic of gene fusions and oncogenic fusion in different cancer types will result in promising new insights from Symposium participants.

EACR members are eligible for reduced registration rates

EACR Meeting Bursaries

Application deadline: 25 January 2019

We will award up to 5 bursaries to assist members of the European Association for Cancer Research to attend the Symposium. The bursaries provide a registration and funds to support travel and accommodation.


  • Applicants must have held a valid membership of the EACR for at least three months prior to the Meeting Bursary application deadline.
  • Only members who are PhD students or who completed their PhD (or equivalent degree) less than four years ago are eligible to apply. Exceptions may be made in the case of researchers who have had a professional break, such as illness or parental leave.



« Back to all meetings

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.